BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33775853)

  • 1. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.
    Kros CJ; Steyger PS
    Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 30559254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
    Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
    Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
    Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
    Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
    Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
    Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
    Mukherjea D; Dhukhwa A; Sapra A; Bhandari P; Woolford K; Franke J; Ramkumar V; Rybak L
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):965-982. PubMed ID: 32757852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
    Crabb SJ; Martin K; Abab J; Ratcliffe I; Thornton R; Lineton B; Ellis M; Moody R; Stanton L; Galanopoulou A; Maishman T; Geldart T; Bayne M; Davies J; Lamb C; Popat S; Joffe JK; Nutting C; Chester J; Hartley A; Thomas G; Ottensmeier C; Huddart R; King E
    Eur J Cancer; 2017 Dec; 87():75-83. PubMed ID: 29128692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
    Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
    Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity.
    Sheehan K; Sheth S; Mukherjea D; Rybak LP; Ramkumar V
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29608150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
    Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
    Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
    Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aucubin protects mouse cochlear hair cells from cisplatin-induced ototoxicity via activation of the PI3K/AKT/STAT3 pathway.
    Jiang Y; Li Z; Ma Q; Dong W; Yao Q; Yu D
    Biochem Pharmacol; 2023 Mar; 209():115440. PubMed ID: 36720354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and restoration of hearing loss associated with the use of cisplatin.
    Chirtes F; Albu S
    Biomed Res Int; 2014; 2014():925485. PubMed ID: 25140325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KL1333, a derivative of β-lapachone, protects against cisplatin-induced ototoxicity in mouse cochlear cultures.
    Lee HS; Kim YR; Lee IK; Kim UK; Baek JI; Lee KY
    Biomed Pharmacother; 2020 Jun; 126():110068. PubMed ID: 32203888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity.
    Waissbluth S; Daniel SJ
    Hear Res; 2013 May; 299():37-45. PubMed ID: 23467171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols.
    Fetoni AR; Paciello F; Troiani D
    Antioxid Redox Signal; 2022 Jun; 36(16-18):1229-1245. PubMed ID: 34731023
    [No Abstract]   [Full Text] [Related]  

  • 20. Ototoxicity: therapeutic opportunities.
    Rybak LP; Whitworth CA
    Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.